PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia.

The transcription of key metabolic regulatory enzymes in the heart is altered in the diabetic state, yet little is known of the underlying mechanisms. The aim of this study was to investigate the role of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in modulating cardiac insulin-sensitive glucose transporter (GLUT-4) protein levels in altered metabolic states and to determine the functional consequences by assessing cardiac ischemic tolerance. Wild-type and PPAR-alpha-null mouse hearts were isolated and perfused 6 wk after streptozotocin administration or after 14 mo on a high-fat diet or after a 24-h fast. Myocardial d-[2-(3)H]glucose uptake was measured during low-flow ischemia, and differences in GLUT-4 protein levels were quantified using Western blotting. In wild-type mice in all three metabolic states, elevated plasma free fatty acids were associated with lower total cardiac GLUT-4 protein levels and decreased glucose uptake during ischemia, resulting in poor postischemic functional recovery. Although PPAR-alpha-null mice also had elevated plasma free fatty acids, they had neither decreased cardiac GLUT-4 levels nor decreased glucose uptake during ischemia and, consequently, did not have poor recovery during reperfusion. We conclude that elevated plasma free fatty acids are associated with increased injury during ischemia due to decreased cardiac glucose uptake resulting from lower cardiac GLUT-4 protein levels, the levels of GLUT-4 being regulated, probably indirectly, through PPAR-alpha activation.

[1]  J. Ingwall.  Transgenesis and cardiac energetics: new insights into cardiac metabolism. , 2004, Journal of molecular and cellular cardiology.

[2]  D. Gauguier,et al.  Gender differences in hypertrophy, insulin resistance and ischemic injury in the aging type 2 diabetic rat heart. , 2004, Journal of molecular and cellular cardiology.

[3]  Kieran Clarke,et al.  Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes , 2003, Circulation.

[4]  D. Severson,et al.  Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[5]  D. Severson,et al.  Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. , 2003, Diabetes.

[6]  Xianlin Han,et al.  A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  W. Kraus,et al.  Fatty Acid Homeostasis and Induction of Lipid Regulatory Genes in Skeletal Muscles of Peroxisome Proliferator-activated Receptor (PPAR) α Knock-out Mice , 2002, The Journal of Biological Chemistry.

[8]  J. Chatham,et al.  Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. , 2002, Cardiovascular research.

[9]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[10]  K. Bulmer,et al.  Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin , 2002 .

[11]  D. Belke,et al.  Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. , 2002, Diabetes.

[12]  K. Clarke,et al.  Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. , 2002, Diabetes.

[13]  D. Severson,et al.  A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.

[14]  J Seydoux,et al.  Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart. , 2001, Journal of lipid research.

[15]  R. Tian,et al.  Responses of GLUT4-Deficient Hearts to Ischemia Underscore the Importance of Glycolysis , 2001, Circulation.

[16]  G. Radda,et al.  Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  D. Severson,et al.  Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[18]  J. Huss,et al.  PPAR signaling in the control of cardiac energy metabolism. , 2000, Trends in cardiovascular medicine.

[19]  T. Ono,et al.  Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity* , 2000, The Journal of Biological Chemistry.

[20]  H. Taegtmeyer,et al.  Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. , 2000, Journal of molecular and cellular cardiology.

[21]  G. Lopaschuk,et al.  Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  D. Kelly,et al.  A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[24]  J. Vanoverschelde,et al.  Glucose for the heart. , 1999, Circulation.

[25]  L. Opie,et al.  Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. , 1998, Cardiovascular research.

[26]  J. Mccormack,et al.  Regulation of energy substrate metabolism in the diabetic heart. , 1997, Cardiovascular research.

[27]  G. Shulman,et al.  Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. , 1997, Circulation.

[28]  G. Radda,et al.  Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. , 1996, Circulation research.

[29]  G. Radda,et al.  The role of Na+/K+ ATPase activity during low flow ischemia in preventing myocardial injury: A 31P, 23Na and 87Rb NMR spectroscopic study , 1995, Magnetic resonance in medicine.

[30]  L. Becker,et al.  Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. , 1995, Circulation research.

[31]  G. Lopaschuk,et al.  Regulation of fatty acid oxidation in the mammalian heart in health and disease. , 1994, Biochimica et biophysica acta.

[32]  G. Lopaschuk,et al.  Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. , 1989, Biochimica et biophysica acta.

[33]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[34]  J. Huss,et al.  Nuclear Receptor Signaling and Cardiac Energetics PPARs and Atherogenesis: Regulators of Gene Expression in Vascular Cells Nuclear Receptor Signaling in the Control of Cholesterol Homeostasis , 2004 .

[35]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[36]  J. Peters,et al.  Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). , 1998, The Journal of biological chemistry.